EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure

S Koay iD, E Vichayanrat iD, F Bremner, F Valerio, R Mackenzie, G Chiaro, G Ingle, P McNamara, L Watson, J N Panicker, M P Lunn, C Mathias und 1 weitere

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.70140 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von S Koay und 12 weiteren Autor:innen. Beteiligte Einrichtung: Autonomic Unit, National Hospital for Neurology and Neurosurgery, London, UK. Hauptthemen laut MEDLINE: Pure Autonomic Failure, Multiple System Atrophy, Norepinephrine, Lewy Body Disease. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Brain Appeal, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Autonomic Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pure autonomic failure (PAF) presents with autonomic failure without other neurological features. A third develop central neurological features, fulfilling criteria for multiple system atrophy (MSA) and Lewy body diseases (LBD), including Parkinson's disease and Dementia with Lewy bodies. We hypothesized multimodal autonomic biomarkers would identify differences between PAF, MSA, and LBD, and predict phenoconversion in patients presenting with PAF.

Methods

This observational cohort study included 391 alpha‐synucleinopathy patients evaluated with cardiovascular autonomic testing, plasma noradrenaline, pupillometry, autonomic symptom, and quality‐of‐life questionnaires. PAF patients were monitored for the emergence of central neurological features. Logistic regression modeling was used to identify autonomic biomarkers at initial assessment that predicted future phenoconversion.

Results

Patients with PAF had more severe orthostatic hypotension, lower supine plasma noradrenaline, and frequent sympathetic pupillary deficits at initial assessment than MSA and LBD. 50/194 (26%) with PAF phenoconverted to MSA or LBD after a median of 13 years, with normal pupils, heart rate response to deep breathing ≥ 10 bpm, and supine plasma noradrenaline ≥ 200 pg/mL predicting future phenoconversion to MSA or LBD, with younger age at presentation and higher supine plasma noradrenaline levels associated with conversion to MSA.

Conclusion

In patients presenting with PAF, normal pupillary function and supine plasma noradrenaline levels with intact cardiovagal responses were red flags for future phenoconversion. Younger patients with higher supine plasma noradrenaline levels were more likely to convert to MSA rather than LBD. A non‐invasive multimodal autonomic assessment can help differentiate between alpha‐synucleinopathies and predict phenoconversion from PAF to MSA or LBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pure Autonomic FailureMultiple System AtrophyNorepinephrineLewy Body DiseaseSynucleinopathiesHumansMaleFemaleAgedMiddle AgedBiomarkersCohort StudiesHypotension, Orthostatic

Stichwörter der Autor:innen

Parkinson's diseaseautonomic failureautonomic testingmultiple system atrophyorthostatic hypotensionpure autonomic failure

Substanzen

BiomarkersNorepinephrine

Autor:innen und Institutionen

  • Autonomic Unit, National Hospital for Neurology and Neurosurgery, London, UK.
  • Department of Translational Neuroscience and Stroke, University College London Queen Square Institute of Neurology, London, UK.
  • Queen Square Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UK.
  • Neuro-Ophthalmology Department, National Hospital for Neurology and Neurosurgery, London, UK.
  • Department of UroNeurology, The National Hospital for Neurology and Neurosurgery, London, UK.

ORCID-Profile: S Koay, E Vichayanrat

Förderung

  • National Brain Appeal
  • National Institute for Health Research University College London Hospitals Biomedical Research Centre
  • Autonomic Charitable Trust
  • Guarantors of Brain

Zitieren

APA

Koay, S., Vichayanrat, E., Bremner, F., Valerio, F., Mackenzie, R., Chiaro, G., Ingle, G., McNamara, P., Watson, L., Panicker, J. N., Lunn, M. P., Mathias, C., & Iodice, V. (2025). Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70140

Vancouver

Koay S, Vichayanrat E, Bremner F, Valerio F, Mackenzie R, Chiaro G, et al. Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70140

BibTeX
@article{Koay2025,
  author = {Koay, S and Vichayanrat, E and Bremner, F and Valerio, F and Mackenzie, R and Chiaro, G and Ingle, G and McNamara, P and Watson, L and Panicker, J N and Lunn, M P and Mathias, C and Iodice, V},
  title = {Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.70140}
}
Kostenlos starten →